Overview
Wan-hong Zhao practices in Xi'an, China. Zhao is rated as a Distinguished expert by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). Their top areas of expertise are Acute Monoblastic Leukemia (AmoL), Multiple Myeloma, Follicular Lymphoma, and Acute Myeloid Leukemia (AML).
Their clinical research consists of co-authoring 17 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Acute Monoblastic Leukemia (AmoL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Monoblastic Leukemia (AmoL)
- Experienced
- Acute Myeloid Leukemia (AML)
- AgranulocytosisZhao isExperienced. Learn about Agranulocytosis.
- Follicular LymphomaZhao isExperienced. Learn about Follicular Lymphoma.
- LeukemiaZhao isExperienced. Learn about Leukemia.
- Multiple MyelomaZhao isExperienced. Learn about Multiple Myeloma.
- Non-Hodgkin LymphomaZhao isExperienced. Learn about Non-Hodgkin Lymphoma.